Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zevra Therapeutics
Pharma
Zevra embarks on diagnosis push as Miplyffa launch gains steam
The company estimates there are around 900 patients with Niemann-Pick disease type C in the U.S.
Zoey Becker
Mar 13, 2025 11:24am
Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025
Feb 28, 2025 10:18am
Zevra lines up $150M from sale of PRV tied to Miplyffa approval
Feb 27, 2025 9:58am
Zevra, nonprofit team up to drive diagnosis of rare diseases
Oct 10, 2024 6:00am
Zevra pegs Miplyffa as 'cornerstone' of Niemann-Pick treatment
Oct 4, 2024 6:45am
IntraBio snags FDA nod in rare disease just days after Zevra
Sep 25, 2024 9:50am
